组织型纤溶酶原激活剂的分离纯化及其与尿激酶的比较。 - Suppr

Suppr

超能文献

Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.

作者信息

Kok P, Astrup T

出版信息

Biochemistry. 1969 Jan;8(1):79-86. doi: 10.1021/bi00829a013.

DOI:10.1021/bi00829a013

PMID:5777345

Abstract

摘要

相似文献

Isolation and purification of a tissue plasminogen activator and its comparison with urokinase.组织型纤溶酶原激活剂的分离纯化及其与尿激酶的比较。

Biochemistry. 1969 Jan;8(1):79-86. doi: 10.1021/bi00829a013.

Urokinase.

Curr Probl Clin Biochem. 1968;2:237-59.

The mechanism of activation of rabbit plasminogen by urokinase. Lack of a preactivation peptide.尿激酶激活兔纤溶酶原的机制。不存在前激活肽。

Biochem Biophys Res Commun. 1974 Sep 23;60(2):729-36. doi: 10.1016/0006-291x(74)90301-5.

The isolation and characterization of plasminogen activators (urokinase) from human urine.从人尿中分离和鉴定纤溶酶原激活剂（尿激酶）。

Biochemistry. 1966 Jul;5(7):2160-9. doi: 10.1021/bi00871a003.

Metabolic fate of urokinase.尿激酶的代谢命运

Chem Pharm Bull (Tokyo). 1974 Apr;22(4):727-35. doi: 10.1248/cpb.22.727.

Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase.尿激酶抗血清对纤溶酶原激活剂的作用：血浆纤溶酶原激活剂与尿激酶之间免疫差异的证明。

J Clin Invest. 1968 Jun;47(6):1238-53. doi: 10.1172/JCI105816.

Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.单链尿激酶型纤溶酶原激活剂不具备可测量的内在酰胺水解或纤溶酶原激活剂活性。

Biochemistry. 1991 Jun 11;30(23):5797-805. doi: 10.1021/bi00237a024.

Isolation and purification of highly enriched tissue plasminogen activator from pig heart.从猪心脏中分离纯化高纯度组织纤溶酶原激活剂

Thromb Diath Haemorrh. 1970 Feb 28;23(1):64-76.

Studies on plasminogen activators. II. A method for the separation of purified urokinase from small samples of urine.

Acta Chem Scand. 1966;20(9):2551-8. doi: 10.3891/acta.chem.scand.20-2551.

Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase.从人类尸体血管树制备纤溶酶原激活剂及其与尿激酶的比较。

J Biochem. 1974 Apr;75(4):731-41. doi: 10.1093/oxfordjournals.jbchem.a130446.

引用本文的文献

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in dogs with femoral vein thrombosis.用人外源性（组织型）纤溶酶原激活剂对患有股静脉血栓形成的犬进行溶栓治疗。

J Clin Invest. 1982 Mar;69(3):573-80. doi: 10.1172/jci110483.

Thrombolysis with human extrinsic (tissue-type) plasminogen activator in rabbits with experimental jugular vein thrombosis. Effect of molecular form and dose of activator, age of the thrombus, and route of administration.用人外源性（组织型）纤溶酶原激活剂对实验性颈静脉血栓形成的家兔进行溶栓治疗。激活剂分子形式和剂量、血栓形成时间以及给药途径的影响

J Clin Invest. 1983 Feb;71(2):368-76. doi: 10.1172/jci110778.

Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.恶性淋巴细胞产生的纯化纤溶酶原激活因子可消除淋巴细胞的细胞毒性。

Clin Exp Immunol. 1984 Jun;56(3):701-8.

Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.由尿激酶或组织型纤溶酶原激活剂激活的血浆中纤溶酶原和纤溶酶抑制剂复合物分子形式的形成顺序。

Biochem J. 1984 Oct 1;223(1):179-87. doi: 10.1042/bj2230179.

Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study.人体组织培养物中的纤溶酶原激活物活性。一项免疫学和组织化学研究。

J Clin Invest. 1969 Sep;48(9):1740-53. doi: 10.1172/JCI106140.

Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.尿激酶在人血浆中产生的纤溶酶原和纤溶酶的不同分子形式及其与蛋白酶抑制剂以及纤维蛋白原和纤维蛋白溶解的关系。

Biochem J. 1974 Nov;143(2):273-83. doi: 10.1042/bj1430273.

Some characteristics of urokinase released in organ culture of human kidney.人肾器官培养中释放的尿激酶的一些特性。

Experientia. 1977 May 15;33(5):589-91. doi: 10.1007/BF01946513.

Purification of plasminogen activators from human seminal plasma.

Biochem J. 1978 May 1;171(2):435-44. doi: 10.1042/bj1710435.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验